|
|
|
Volumn 365, Issue 15, 2011, Pages 1449-1450
|
|
Vemurafenib in melanoma with BRAF V600E mutation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
VEMURAFENIB;
BRAF GENE;
CANCER SURVIVAL;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
GENE MUTATION;
HAZARD RATIO;
HEALTH CARE COST;
HEALTH CARE SYSTEM;
HUMAN;
LETTER;
MELANOMA;
ONCOGENE;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
DACARBAZINE;
FEMALE;
HUMANS;
INDOLES;
MALE;
MELANOMA;
PROTO-ONCOGENE PROTEINS B-RAF;
SULFONAMIDES;
|
|
EID: 80054034905
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (19)
|
|
References (4)
|
